Medtronic plc logo

Medtronic plc (MDT)

Market Closed
24 Feb, 20:00
NYSE NYSE
$
96. 75
-1.86
-1.89%
$
124.23B Market Cap
25.14 P/E Ratio
2.76% Div Yield
6,197,859 Volume
5.2 Eps
$ 98.61
Previous Close
Day Range
96.57 98.69
Year Range
79.55 106.33
Want to track MDT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
MDT earnings report is expected in 84 days (20 May 2026)
Medtronic (MDT) Tops Q3 Earnings Estimates

Medtronic (MDT) Tops Q3 Earnings Estimates

Medtronic (MDT) came out with quarterly earnings of $1.39 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.30 per share a year ago.

Zacks | 1 year ago
Medtronic credits heart-surgery-device growth as profit tops analyst estimates

Medtronic credits heart-surgery-device growth as profit tops analyst estimates

Medtronic said it is “starting to see the results” of its investment in new products.

Marketwatch | 1 year ago
Medtronic beats quarterly profit estimates on strong heart, diabetes device sales

Medtronic beats quarterly profit estimates on strong heart, diabetes device sales

Medtronic beat Wall Street estimates for quarterly profit on Tuesday, on strong demand for its heart and diabetes devices.

Reuters | 1 year ago
Medtronic: Several Reasons For Optimism Before The Upcoming Earnings Release

Medtronic: Several Reasons For Optimism Before The Upcoming Earnings Release

Medtronic: Several Reasons For Optimism Before The Upcoming Earnings Release

Seekingalpha | 1 year ago
Medtronic (MDT) Increases Yet Falls Behind Market: What Investors Need to Know

Medtronic (MDT) Increases Yet Falls Behind Market: What Investors Need to Know

In the closing of the recent trading day, Medtronic (MDT) stood at $92.20, denoting a +0.93% change from the preceding trading day.

Zacks | 1 year ago
Seeking Clues to Medtronic (MDT) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

Seeking Clues to Medtronic (MDT) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

Beyond analysts' top -and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended January 2025.

Zacks | 1 year ago
Retirement Strategy: 2 Dividend Aristocrats At Bargain Prices

Retirement Strategy: 2 Dividend Aristocrats At Bargain Prices

Buying battle-tested dividend aristocrats can be a winning strategy for those seeking durable retirement income. What's even better is if they also carry strong balance sheets and are attractively valued. In this article, I highlight 2 such picks, which, on a combined basis, offer immediate diversification and potential for market-beating total returns.

Seekingalpha | 1 year ago
MDT Stock Trades Cheaper Than Peers Ahead of Q3 Earnings: Time to Buy?

MDT Stock Trades Cheaper Than Peers Ahead of Q3 Earnings: Time to Buy?

Medtronic expects its fiscal 2025 third-quarter revenues to reflect an unfavorable impact of 1% from currency translation.

Zacks | 1 year ago
Medtronic (MDT) Laps the Stock Market: Here's Why

Medtronic (MDT) Laps the Stock Market: Here's Why

In the closing of the recent trading day, Medtronic (MDT) stood at $91.69, denoting a +0.79% change from the preceding trading day.

Zacks | 1 year ago
Medtronic (MDT) Outperforms Broader Market: What You Need to Know

Medtronic (MDT) Outperforms Broader Market: What You Need to Know

In the most recent trading session, Medtronic (MDT) closed at $91.99, indicating a +0.63% shift from the previous trading day.

Zacks | 1 year ago
3 Reasons to Buy Medtronic Stock Like There's No Tomorrow

3 Reasons to Buy Medtronic Stock Like There's No Tomorrow

Shares of Medtronic (MDT 0.32%) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices giant had some weakness in recent years amid disappointing trends from its diabetes segment, but it appears to have finally turned the corner with its increasingly diversified operating profile.

Fool | 1 year ago
1 Top Dividend Stock to Buy in 2025, and 1 to Avoid

1 Top Dividend Stock to Buy in 2025, and 1 to Avoid

When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even more than the dividend yield. Corporations with high yields may look attractive, but sometimes these are unsustainable.

Fool | 1 year ago
Loading...
Load More